Built by experienced leaders in medicine, healthcare policy, payer-provider relations and technology
Amol Navathe, MD, PhD, is a distinguished thought leader, healthcare executive, scholar, and entrepreneur committed to innovation and public service in healthcare. Dr. Navathe’s experience includes major contributions to health policy, healthcare technology, and academia. He is an active clinician with experience in both primary care and hospital-based settings. Dr. Navathe founded Otter Health as a mission-driven company to improve the quality of health care while reducing administrative burden for patients, providers, and plans. He is a tenured Professor in the Departments of Health Policy, Healthcare Management and Economics (The Wharton School), and Medicine at the University of Pennsylvania.
Dr. Navathe recently served as the Vice Chairman and Commissioner of the Medicare Payment Advisory Commission (MedPAC), a nonpartisan agency that advises the US Congress and the Centers for Medicare and Medicaid Services on Medicare policy. He previously was co-founder of Embedded Healthcare (now Clarify Health), a health care technology company that brings behavioral economics solutions to improving affordability and quality. Throughout his career, Dr. Navathe has served on several boards. He is a Director on the Boards of The SCAN Group and Hawaii Medical Services Association, The Blue Cross Blue Shield of Hawaii. He also served on the Board of the United States Multi-Payer Claims Database Initiative from 2010-2014.
Dr. Navathe is a leading scholar on payment model design and evaluation, applications of behavioral economics to clinician decision-making, and applications of machine learning and artificial intelligence to health data. His thought leadership led to the founding of a disciplinary academic journal, Health Care: The Journal of Delivery Science and Innovation, serving as its Co-Editor-in-Chief. Dr. Navathe completed his medical training at the University of Pennsylvania School of Medicine and his post-graduate medical training at the Brigham and Women’s Hospital at Harvard Medical School. He obtained his PhD in Health Care Management and Economics from The Wharton School at the University of Pennsylvania.
Keith Florance leads the company's mission to transform UM in healthcare with the conviction that traditional PA processes create unnecessary friction in healthcare delivery while failing to achieve meaningful cost management. He's been in the space for over twenty years and is still very frustrated that he hasn't solved US Healthcare yet!
Before leading Otter Health, Keith led Clarify Health's Payer vertical as GM after his prior startup Embedded Healthcare was acquired in. Keith built Embedded Healthcare alongside Amol and is thrilled to be partnered up again! He was also a Partner in the healthcare sector at Boston Consulting Group and an early transformation lead at Evolent. Keith earned a BS in Biomedical Engineering at Johns Hopkins and an MBA from the Darden School of Business.
Keith is a thought leader in healthcare innovation, focusing on the intersection of network strategy, value-based care, and technology-enabled utilization management. He's also got two amazing boys, runs over 1000 miles a year, and has way too many bikes.
Ram Keralapura is a seasoned technologist, builder, and startup veteran with a deep passion for innovation, data, and all things analytical. He holds a Bachelor's degree in Electrical Engineering, a Master's in Computer Science, and a Ph.D. in Computer Engineering. Over the course of his academic and professional career, he has authored more than 30 peer-reviewed publications and holds over 20 patents granted by the U.S. Patent and Trademark Office.
Much of his professional journey has been rooted in the startup ecosystem, where he has frequently served as an early employee and played pivotal roles in driving product and technical strategy. Several of the startups he contributed to have achieved successful exits through acquisitions or IPOs. Notably, one of his ventures was acquired by Google, where he spent three years leading the Data Science and Machine Learning team within Google Cloud Security. His expertise spans a range of industries, including cybersecurity, public health risk assessment, and insurance technology, where he has applied advanced machine learning and data science to solve complex, high-impact problems.
Outside of work, he is an avid sports enthusiast — especially passionate about tennis — and a devoted animal lover. He enjoys spending quality time with his puppy, who serves as both his daily companion and occasional virtual meeting guest.
Will Bartlett is a computer scientist turned entrepreneur with a passion for data-driven solutions and innovation. Having started on the clinical medicine path as an MD candidate at the Mount Sinai School of Medicine, Will was inspired by the potential of technology to revolutionize healthcare and left after a year to pursue a career in healthcare technology.
A "former future doctor," Will went on to earn a Master of Science in Computer Science from Georgia Tech, where he published on applications of machine learning to biomedical wearable sensor data, and later completed his MBA at the Wharton School of Business. Will has spent years working with healthcare data of all shapes and sizes, with experience in both the real-world data for oncology and the payer-provider spaces. His career has shown a particular focus on applications of AI and machine learning for utilization management.
Will's personal and professional experiences have given him the conviction that there is no industry with more obsolescence, scale, and opportunity for impact than healthcare–and that technology can lead that transformation. Outside of work, Will is an avid player of all racket sports, though he agrees there are far too many. You can also find him on the rock climbing wall or sitting at a chess board in a New York City park.
Ezekiel J. Emanuel, MD, PhD, is Vice Provost for Global Initiatives and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania. He holds appointments in the Department of Medical Ethics and Health Policy in the Perelman School of Medicine and the Department of Health Care Management in the Wharton School.
Dr. Emanuel is an oncologist and world leader in health policy and bioethics. He is a Special Advisor to the Director General of the World Health Organization, Senior Fellow at the Center for American Progress, and member of the Council on Foreign Relations. He was founding chair of the Department of Bioethics at the National Institutes of Health and held that position until August of 2011. From 2009 to 2011, he served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. In this role, he was instrumental in drafting the Affordable Care Act (ACA). He also served on the Biden-Harris Transition Covid Advisory Board.
Dr. Emanuel is the most widely cited bioethicist in history. He has over 350 publications and has authored or edited 16 books. Recent books include Eat Your Ice Cream (2026), Which Country Has the World’s Best Health Care (2020), Prescription for the Future (2017), Reinventing American Health Care: How the Affordable Care Act Will Improve our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System (2014) and Brothers Emanuel (2013).
Dr. Emanuel regularly contributes to the New York Times, the Washington Post, the Wall Street Journal, The Atlantic, and appears on BBC, NPR, CNN, MSNBC, CNBC and other media outlets.
He has received numerous awards including election to the Institute of Medicine (IOM) of the National Academy of Science, the American Academy of Arts and Sciences, the Association of American Physicians, and the Royal College of Medicine (UK). He received –but refused— a Fulbright Scholarship. He was a Guggenheim Fellow.
He has been named the Dan David Prize Laureate in Bioethics, a recipient of the AMA-Burroughs Wellcome Leadership Award, the Public Service Award from the American Society of Clinical Oncology, Lifetime Achievement Award from the American Society of Bioethics and Humanities, Robert Wood Johnson Foundation David E. Rogers Award, President's Medal for Social Justice Roosevelt University, the John Mendelsohn Award from the MD Anderson Cancer Center and recipient of the Patricia Price Browne Prize in Biomedical Ethics.
Dr. Emanuel received honorary degrees from Icahn School of Medicine at Mt. Sinai, Union Graduate College, the Medical College of Wisconsin, and Macalester College.
Dr. Emanuel earned an MD (1988) and a PhD in political philosophy (1989) from Harvard University, an MSc in biochemistry from Oxford University (1981), and a BA in chemistry from Amherst College (1979).
Dr. Kate Goodrich serves as Executive in Residence at Optum, where she serves as a mentor and advisor to medical professionals across the organization. In this role, she supports clinician enablement, continuous clinical learning and helps to uphold the highest standards of clinical excellence in the delivery of care to patients.
Dr. Goodrich was previously the Chief Medical Officer at Humana, where she provided executive clinical leadership across the enterprise. She led clinician engagement and retention, healthcare clinical and health services research and efforts to advance the Company’s value-based care and integrated senior care strategies.
Prior to Humana, she held several leadership roles at the Centers for Medicare and Medicaid Services (CMS), including CMS Chief Medical Officer and Director of the Center for Clinical Standards and Quality.
Earlier in her career, Kate served on the faculty at the George Washington University School of Medicine and Health Sciences (GW), where she served as the Director of Hospital Medicine and chaired the Institutional Review Board. She continues to practice as a hospitalist and clinical professor of medicine at GWU.
Kate earned her medical degree from Louisiana State University School of Medicine and her master’s in health services research from Yale University through the Robert Wood Johnson Clinical Scholars Program. She completed her residency in internal medicine and served as a Chief Medical Resident at GWU.
She currently serves on the boards of Tarsus Pharmaceuticals, the National Quality Forum, the Institute for Accountable Care and is a member of the Advisory Board for the Parity Center at the University of Pennsylvania and Otter Health.
